Beatson West of Scotland Cancer Centre, Glasgow, UK; Institute of Cancer Sciences, University of Glasgow, UK.
Beatson West of Scotland Cancer Centre, Glasgow, UK.
Radiother Oncol. 2017 Oct;125(1):1-12. doi: 10.1016/j.radonc.2017.08.003. Epub 2017 Aug 28.
Malignant pleural mesothelioma (MPM) is a devastating disease with limited treatment options and a dismal prognosis. Attempts to employ radical radiotherapy in this disease have been limited by the complex shape of the pleura and the dose restrictions necessitated by the close proximity of radiosensitive structures. Recent shifts towards a 'lung sparing' surgical approach in MPM have further heightened these challenges. The aim of this systematic review is to assess recent advances in radiotherapy planning and delivery, to ascertain how these developments have impacted on the feasibility of delivering photon-based, high-dose radiotherapy with radical intent in MPM. Three electronic databases were searched and a total of 249 articles reviewed. The challenge of generating high quality, practice-defining data for diseases such as MPM was highlighted by the identification of just two randomised studies. Much of the literature consisted of low quality, retrospective data with small cohorts and inconsistent reporting on radiotherapy techniques and dosimetry. Nevertheless, a number of prospective phase II studies were identified to suggest that radical doses of radiotherapy can be delivered safely after a lung sparing procedure in MPM, reporting encouraging survival data and acceptable levels of toxicity.
恶性胸膜间皮瘤(MPM)是一种破坏性疾病,治疗选择有限,预后不佳。由于胸膜的复杂形状以及靠近放射敏感结构所必需的剂量限制,在该疾病中尝试采用根治性放疗受到限制。最近在 MPM 中向“肺保护”手术方法的转变进一步加剧了这些挑战。本系统评价的目的是评估放射治疗计划和实施的最新进展,以确定这些进展如何影响在 MPM 中用根治性意图提供基于光子的高剂量放疗的可行性。对三个电子数据库进行了搜索,并对总共 249 篇文章进行了综述。仅确定了两项随机研究,突出了为 MPM 等疾病生成高质量、具有实践定义的数据的挑战。大部分文献为低质量的回顾性数据,队列规模较小,放射治疗技术和剂量学的报告不一致。尽管如此,仍确定了一些前瞻性 II 期研究,表明在 MPM 中进行肺保护手术后可以安全地给予根治剂量的放疗,报告了令人鼓舞的生存数据和可接受的毒性水平。